Shire Pharma Sites Marketing In Eire
UK-based Shire Pharmaceuticals is to extend its sales and marketing operations to the Republic of Ireland, starting with the launch of its prescription products, including the calcium preparations Calcichew and Calcichew D3, and its range of psoriasis and eczema treatments.
Shire says it is committed to growth in its operations in Ireland, and notes that it presently has 11 products in development for the treatment of osteoporosis and other metabolic bone disorders, Alzheimer's disease and chronic fatigue syndrome, which in due course it intends to register and market in Eire.
The company is also actively looking to license in additional products, particularly in the field of metabolic bone diseases, to further extend its operations in the Irish market. Brian Martin (ex-Roche) has been appointed to establish the company's sales and marketing activities, and Cahill May Roberts will be Shire's sole distributor.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze